Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer

NCT03414684 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Carboplatin
DRUG: Nivolumab

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]